Safety of Tumor Necrosis Factor Inhibitor Therapy in Patients With a Prior Malignancy

International Journal of Rheumatic Diseases - United Kingdom
doi 10.1111/1756-185x.12852
Full Text
Abstract

Available in full text

Categories
Rheumatology
Date
Authors
Publisher

Wiley

Related search

Tumor Necrosis Factor Inhibitor–Associated Dermatomyositis

Archives of Dermatology
2010English

Influence of Anti-Tumor Necrosis Factor Therapy on Cancer Incidence in Patients With Rheumatoid Arthritis Who Have Had a Prior Malignancy: Results From the British Society for Rheumatology Biologics Register

Arthritis Care and Research
Rheumatology
2010English

Efficacy of Vedolizumab Induction and Maintenance Therapy in Patients With Ulcerative Colitis, Regardless of Prior Exposure to Tumor Necrosis Factor Antagonists

Clinical Gastroenterology and Hepatology
HepatologyGastroenterology
2017English

Effectiveness and Safety of Adalimumab in Patients With Ankylosing Spondylitis or Psoriatic Arthritis and History of Anti-Tumor Necrosis Factor Therapy

Arthritis Research and Therapy
RheumatologyAllergyImmunology
2010English

Successful Treatment of Refractory Behçet’s Myositis With Tumor Necrosis Factor Inhibitor

Hong Kong Bulletin on Rheumatic Diseases
2018English

Chronic Recurrent Multifocal Osteomyelitis: Treatment With a Tumor Necrosis Factor-Alpha Inhibitor

Turkish Journal of Rheumatology
2013English

Tumor Necrosis Factor-Alpha Inhibitor Treatment for Sarcoidosis

Therapeutics and Clinical Risk Management
2008English

PMS73 Visualizing Treatment Patterns of Veteran Patients With Rheumatoid Arthritis Who Initiated Tumor Necrosis Factor Therapy

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2012English

Antioxidants and Tumor Necrosis Factor-Α in Patients With Pulmonary Tuberculosis

Journal of High Institute of Public Health
2010English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy